Clinical Trial Update: Skin Transcriptional Profiles In Psoriatic Patients Under Adalimumab Biotherapy [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating skin transcriptional profiles in patients with chronic plaque psoriasis treated with adalimumab; study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• ADALIMUMAB (ADALIMUMAB-AATY)

Snippet

Sponsor: Poitiers University Hospital | Conditions: Chronic Plaque Psoriasis | Phase 2 | Status: COMPLETED